Back

Selection matters: clinical indication, not timing, determines angiographic success in late-presenting STEMI

29 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Acute myocardial infarction: contemporary challenges ST-Elevation Myocardial Infarction (STEMI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alexis Zambrano Zambrano

National Institute of Cardiology Ignacio Chavez, Mexico City (Mexico)

4 More presentations in this session

Presentation thumbnail
Impact of coronary artery ectasia on revascularization strategies and echocardiographic characteristics in patients presenting with ST-segment elevation myocardial infarction
Doctor L. Caunite (Leiden, NL)
Abstract
Presentation thumbnail
Contemporary heart failure and mortality burden after STEMI: insights from a real-world cohort
Doctor R. Aggarwal (Boston, US)
Abstract
Presentation thumbnail
Clonal hematopoiesis of indeterminate potential and stress hyperglycemia ratio among patients with STEMI---from a prospective cohort study
Ms L. Xue (CN)
Abstract
Presentation thumbnail
Comparative clinical outcomes of nebivolol versus bisoprolol in patients with STEMI after primary PCI: a propensity-score matched analysis
Professor J. Park (Deajeon, KR)
Abstract

Access the full session

Session thumbnail
Acute myocardial infarction: contemporary challenges

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
At the outer edge of STEMI time: even after 12 hours, the clock keeps ticking.
27 August 2022
thumbnail
Congress Presentation
Angiographic phenotypes and predictors of acute complications in spontaneous coronary artery dissection: insights from a single-centre registry
21 March 2026
thumbnail
Congress Presentation
Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
27 August 2022
thumbnail
Congress Presentation
The new occlusive/non-occlusive MI paradigm to remedy the failure of high risk non-ST elevation MI criteria in the real world - insights from the DIFOCCULT-3 trial
19 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources